Profile

Ava Crum

United Kingdom

Medixo Centre

Androgen-deprivation therapy is the mainstay of treatment for the management of advanced prostate carcinoma till transition to castration-resistant prostate carcinoma (CRPC). Recently, adrenal and intratumoral synthesis of androgens has been found to be the major cause for CRPC. Abiraterone acetate is an orally active, potent and selective inhibitor of 17 a hydroxylase and c 17, 20 lyase, which acts by decreasing the de novo production of androgens with no rise in steroids downstream. Multiple randomized trials have shown significant improvement of >50% decline in prostate-specifi

Last activity: on 14/08/2020

Joined: on 14/08/2020

https://www.medixocentre.com/abiraterone-cost https://www.medixocentre.com/abiraterone-250-mg-tablets https://www.medixocentre.com/zytiga-cost abirateronecost

Design quotient

Earn DQ points
by participating
in a challenge.

What are (DQ) Points?

DQ points are a measure of your contributions, they correspond to how active you are in the Research, Ideas and Evaluation phases of a challenge.

Design quotient

Earn DQ points by participating in a challenge.

What are (DQ) Points?

Earn DQ points
by participating
in a challenge.